Skip to main content

Table 1 Baseline characteristics of patients before and after propensity score matching in the non-randomized arm

From: Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)

 

Non-randomized arm

Pre-PS matching

Post-PS matching

Standardized difference

Surgery only (NR-Group S) n = 641

Surgery plus UFT/LV (NR-Group U) n = 1,239

Total (NR-Group) N = 1,880

Surgery only (NR-Group S) n = 402

Surgery plus UFT/LV (NR-Group U) n = 804

Pre-PS matching

Post-PS matching

Agea, years

 Mean ± SD

69.9 ± 8.1

65.1 ± 9.9

66.7 ± 9.6

66.7 ± 8.5

64.4 ± 9.4

—

—

 Median [range]

71 [34–80]

66 [29–80]

68 [29–80]

67 [34–80]

65 [29–80]

—

—

  < 70

264 (41.2)

771 (62.2)

1,035 (55.1)

264 (65.7)

555 (69.0)

0.431

0.072

  ≥ 70

377 (58.8)

468 (37.8)

845 (44.9)

138 (34.3)

249 (31.0)

—

—

 Sexa, male

369 (57.6)

654 (52.8)

1,023 (54.4)

216 (53.7)

454 (56.5)

0.096

0.055

Risk factors for recurrencea

 T4 disease

302 (47.1)

720 (58.1)

1,022 (54.4)

217 (54.0)

460 (57.2)

0.222

0.065

 Perforation/penetration

52 (8.1)

148 (11.9)

200 (10.6)

49 (12.2)

116 (14.4)

0.128

0.066

 Poorly differentiated adenocarcinoma

46 (7.2)

127 (10.3)

173 (9.2)

39 (9.7)

87 (10.8)

0.109

0.037

 Mucinous carcinoma

72 (11.2)

190 (15.3)

262 (13.9)

65 (16.2)

120 (14.9)

0.121

0.034

 No. of lymph nodes dissected < 12

298 (46.5)

403 (32.5)

701 (37.3)

149 (37.1)

269 (33.5)

0.289

0.076

 No. of patients at institution ≥ 5

549 (85.6)

969 (78.2)

1,518 (80.7)

331 (82.3)

653 (81.2)

0.194

0.029

Performance status

 0

589 (91.9)

1,175 (94.8)

1,764 (93.8)

367 (91.3)

756 (94.0)

0.119

0.105

 1

52 (8.1)

64 (5.2)

116 (6.2)

35 (8.7)

48 (6.0)

—

—

Surgical approach

 Laparoscopy

404 (63.0)

675 (54.5)

1,079 (57.4)

237 (59.0)

430 (53.5)

0.174

0.110

 Laparotomy

237 (37.0)

564 (45.5)

801 (42.6)

165 (41.0)

374 (46.5)

—

—

Histology

 Papillary and tubular

525 (81.9)

928 (74.9)

1,453 (77.3)

300 (74.6)

602 (74.9)

0.171

0.006

 Poorly differentiated and other

116 (18.1)

311 (25.1)

427 (22.7)

102 (25.4)

202 (25.1)

—

—

Depth of tumor invasion (TNM classification)

 T3

339 (52.9)

519 (41.9)

858 (45.6)

185 (46.0)

344 (42.8)

0.222

0.065

 T4

302 (47.1)

720 (58.1)

1,022 (54.4)

217 (54.0)

460 (57.2)

—

—

Lymph node dissection

 Mean ± SD

17.9 ± 13.3

21.0 ± 14.3

20.0 ± 14.0

19.9 ± 14.0

20.7 ± 13.7

0.228

0.055

 Median [range]

13 [1–107]

18 [1–129]

17 [1–129]

16 [1–107]

18 [1–89]

—

—

Lymphatic invasion

 Ly0

285 (44.5)

501 (40.4)

786 (41.8)

170 (42.3)

321 (39.9)

0.081b

0.048

  ≥ Ly1

356 (55.5)

737 (59.5)

1,093 (58.1)

232 (57.7)

483 (60.1)

—

—

 Missing

0 (0.0)

1 (0.1)

1 (0.1)

0 (0.0)

0 (0.0)

—

—

Venous invasion

 V0

235 (36.7)

400 (32.3)

635 (33.8)

149 (37.1)

256 (31.8)

0.092b

0.110

  ≥ V1

406 (63.3)

838 (67.6)

1,244 (66.2)

253 (62.9)

548 (68.2)

—

—

 Missing

0 (0.0)

1 (0.1)

1 (0.1)

0 (0.0)

0 (0.0)

—

—

Tumor location

 Right colon (C, A, T)

253 (39.5)

550 (44.4)

803 (42.7)

167 (41.5)

355 (44.2)

0.100

0.053

 Left colon (D, S, RS)

388 (60.5)

689 (55.6)

1,077 (57.3)

235 (58.5)

449 (55.8)

—

—

  1. Values presented as n (%) unless otherwise specified. NR-Group S: patients underwent surgery alone; NR-Group U: patients underwent surgery followed by UFT/LV
  2. aUsed for PS matching
  3. bMissing data excluded from calculation
  4. —: Not applicable
  5. Abbreviations: A Ascending colon, C Cecum, D Descending colon, NR Non-randomized, PS Propensity score, RS Rectosigmoid colon, S Sigmoid colon, SD Standard deviation, T Transverse colon, TNM Tumor, node, metastasis, UFT/LV Uracil sand tegafur plus leucovorin